Author

Angel Lanas

Epidemiological overview
Epidemiological overview

Angel Lanas

MANAGEMENT OF HELICOBACTER PYLORI INFECTION DURING THE LAST DECADE: TEMPORAL PRESCRIPTION TRENDS FOR THE FIRST-LINE OF NON-ALLERGIC PATIENTS AND ITS ADEQUACY TO CLINICAL GUIDELINES
MANAGEMENT OF HELICOBACTER PYLORI INFECTION DURING THE LAST DECADE: TEMPORAL PRESCRIPTION TRENDS FOR THE FIRST-LINE OF NON-ALLERGIC PATIENTS AND ITS ADEQUACY TO CLINICAL GUIDELINES

Angel Lanas  et al.

FIRST-LINE HELICOBACTER PYLORI ERADICATION RATE IN DAILY CLINICAL PRACTICE IN TWO SPANISH MEDICAL CENTERS: 2010-2019
FIRST-LINE HELICOBACTER PYLORI ERADICATION RATE IN DAILY CLINICAL PRACTICE IN TWO SPANISH MEDICAL CENTERS: 2010-2019

Angel Lanas  et al.

ERRORS IN EMPIRICAL ANTIBIOTIC THERAPIES FOR HELICOBACTER PYLORI ERADICATION IN 45,778 PATIENTS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ERRORS IN EMPIRICAL ANTIBIOTIC THERAPIES FOR HELICOBACTER PYLORI ERADICATION IN 45,778 PATIENTS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Angel Lanas  et al.

MISTAKES IN DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF HELICOBACTER PYLORI INFECTION IN THE LAST DECADE
MISTAKES IN DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF HELICOBACTER PYLORI INFECTION IN THE LAST DECADE

Angel Lanas  et al.

CHARACTERISTICS OF PATIENTS WITH HELICOBACTER PYLORI INFECTION WHO STOP CLINICAL SURVEILLANCE IN GASTROENTEROLOGY CLINICS
CHARACTERISTICS OF PATIENTS WITH HELICOBACTER PYLORI INFECTION WHO STOP CLINICAL SURVEILLANCE IN GASTROENTEROLOGY CLINICS

Angel Lanas  et al.

EVALUATION OF THE ACCURACY OF THE "LIAISON(R) MERIDIAN HELICOBACTER PYLORI SA" STOOL ANTIGEN TEST FOR THE DIAGNOSIS OF H. PYLORI INFECTION: A SPANISH MULTICENTRE STUDY
EVALUATION OF THE ACCURACY OF THE "LIAISON(R) MERIDIAN HELICOBACTER PYLORI SA" STOOL ANTIGEN TEST FOR THE DIAGNOSIS OF H. PYLORI INFECTION: A SPANISH MULTICENTRE STUDY

Angel Lanas  et al.

EVIDENCE-BASED SELECTION ON THE APPROPRIATE FIT CUT-OFF POINT IN CRC SCREENING PROGRAMS IN THE COVID PANDEMIC
EVIDENCE-BASED SELECTION ON THE APPROPRIATE FIT CUT-OFF POINT IN CRC SCREENING PROGRAMS IN THE COVID PANDEMIC

Angel Lanas  et al.

EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 8,000 PATIENTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 8,000 PATIENTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

Angel Lanas  et al.

THERMAL LIQUID BIOPSY PROFILES FROM PANCREATIC CANCER PLASMA SAMPLES CLUSTERED ACCORDING TO DIAGNOSIS AND PROGNOSIS CLINICAL DATA
THERMAL LIQUID BIOPSY PROFILES FROM PANCREATIC CANCER PLASMA SAMPLES CLUSTERED ACCORDING TO DIAGNOSIS AND PROGNOSIS CLINICAL DATA

Angel Lanas  et al.

ROLE OF PROTON PUMP INHIBITORS DOSAGE IN THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ROLE OF PROTON PUMP INHIBITORS DOSAGE IN THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Angel Lanas  et al.

EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2021: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2021: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Angel Lanas  et al.

EFFECTIVENESS AND SAFETY OF HIGH-DOSE DUAL THERAPY: RESULTS OF THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
EFFECTIVENESS AND SAFETY OF HIGH-DOSE DUAL THERAPY: RESULTS OF THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

Angel Lanas  et al.

COMPARISON OF THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION REGIMENS BETWEEN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
COMPARISON OF THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION REGIMENS BETWEEN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Angel Lanas  et al.

DIFFERENCES OF HELICOBACTER PYLORI DIAGNOSTICS AND TREATMENTS IN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
DIFFERENCES OF HELICOBACTER PYLORI DIAGNOSTICS AND TREATMENTS IN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Angel Lanas  et al.

EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG): ANALYSIS OF 2,254 EMPIRICAL RESCUE THERAPIES ON THIRD AND SUBSEQUENT LINES
EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG): ANALYSIS OF 2,254 EMPIRICAL RESCUE THERAPIES ON THIRD AND SUBSEQUENT LINES

Angel Lanas  et al.

IMPACT OF THE COVID-19 PANDEMIC IN THE DIAGNOSIS AND CHARACTERISTICS OF COLORECTAL CANCER PATIENTS
IMPACT OF THE COVID-19 PANDEMIC IN THE DIAGNOSIS AND CHARACTERISTICS OF COLORECTAL CANCER PATIENTS

Angel Lanas  et al.

EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

Angel Lanas  et al.

ROLE OF THE PROTON PUMP INHIBITORS IN HELICOBACTER PYLORI ERADICATION: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ROLE OF THE PROTON PUMP INHIBITORS IN HELICOBACTER PYLORI ERADICATION: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Angel Lanas  et al.

ROLE OF COMPLIANCE IN HELICOBACTER PYLORI TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ROLE OF COMPLIANCE IN HELICOBACTER PYLORI TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Angel Lanas  et al.

Item 1 - 20 / 27
1
2